公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	TRPML1 ameliorates seizures-related neuronal injury by regulating autophagy and lysosomal biogenesis via Ca2+/TFEB signaling pathway.		Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Inhibition of type I interferon signalling is involved in the anti-atherogenic effects of Andrographis paniculata.
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Activation Of Endothelial Transient Receptor Potential Vanilloid 4 Exacerbates Myocardial Ischemia-Reperfusion Injury Via Vascular Integrity Impairment.
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.	6	Neuroscience Bulletin
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Exploring the effect of capsaicin on gene expression and chemotherapy sensitization in gastric cancer cells.
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	ERP29 regulates the proliferation of endometrial carcinoma via M6A modification.	5	Life Sciences
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Sexually dimorphic acetyl‐CoA biosynthesis and utilization in response to drought and exogenous acetic acid.	6	The Plant Journal
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Overexpression of NLRP12 enhances macrophage immune response and alleviates herpes simplex keratitis.	5	Frontiers in Cellular and Infection Microbiology
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Photothermal Sensitive Nanocomposite Hydrogel for Infectious Bone Defects.
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Highly ordered nanotube-like microstructure on titanium dental implant surface fabricated via anodization enhanced cell adhesion and migration of human gingival fibroblasts.	7	International Journal of Nanomedicine

首页上一页 319 320 321 322 323 324 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部